Over-expression of IRF4 in CLL cells reduces BCR signaling, including BCR-induced AKT and ERK phosphorylation and calcium release, and this effect has been proposed to be mediated at least partially through decreased expression of SYK and IKAROS [41]. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.